Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology [5]

Neurology

Volumn 68, Issue 1, 2007, Pages 80-

  Aarsland, D ^a   Emre, M ^a   Lees, A ^a   Poewe, W ^a   Ballard, C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; PLACEBO; RIVASTIGMINE;

CLINICAL TRIAL; DEMENTIA; DEPRESSION; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; PARKINSON DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TREATMENT OUTCOME; UNIFIED PARKINSON DISEASE RATING SCALE;

DEMENTIA; DEPRESSIVE DISORDER; HUMANS; NEUROLOGY; PARKINSON DISEASE; PSYCHOTIC DISORDERS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 33846089693     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000252956.34585.a6     Document Type: Letter

References (0)